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Introduction
Ribosome Biogenesis and Protein Synthesis
Translation, or protein synthesis, is defined as the process in which mRNAs,
previously transcribed from DNA and processed, are decoded by ribosomes to make
proteins. Ribosomes are essential macromolecular machines necessary to synthetize
proteins from information encoded by mRNAs. The active ribosome is called 80S,
from its apparent sedimentation velocity, and is composed of two subunits, namely
the 60S (large) and 40S (small). These two subunits are made of ribosomal RNA
(rRNA) and Ribosomal Proteins (RPs), in particular the 60S contains three rRNAs
(28S, 5S and 5.8S) and 46 RPs, while the 40S is formed by only a single rRNA (18S)
and 33 RPs [1, 2].
Ribosome biogenesis, one of the most energy-demanding process in cell [3], begins in
the nucleolus with the transcription by RNAPolI of a polycystronic gene encoding
28S, 18S and 5.8S rRNA molecules, producing the 47S precursor. For the tran-
scription of this precursor in mammals, at least three basal factors are necessary:
the Transcription Initiation Factor I (TIF-I), the Selectivity factor 1 (SL1), and
the Upstream Binding Factor (UBF) [4, 5]. The RPs’ mRNAs are transcribed by
RNAPolII, then they are translated in the cytoplasm. RPs then are imported in
the nucleolus where they assemble with the rRNAs [6] and with the 5S rRNA, tran-
scribed separately (by RNAPolIII). All together they form the 90S precursor, that is
subsequentely cleaved in 66S and 43S pre-ribosomes. These pre-ribosomes are then
transported into the cytoplasm to complete their maturation. Ribosome biogenesis is
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2a process strictly regulated and its rate is controlled by cell proliferation-controlling
processes [7].
Translation can be divided in four major steps: initiation, elongation, termination
and ribosomal recycling. Each of these steps is assisted by protein factors, called
eukaryotic initiation factors (eIFs), eukaryotic elongation factors (eEFs) and eu-
karyotic termination factors (eRFs), which transiently associate with the ribosome
and/or the mRNA. Translation initiation consists in a series of events that leads up
to the recruitment of an elongation-competent 80S ribosome at the start codon of
an mRNA. The elongation phase consists in the polypeptide synthesis. Lastly, the
completed polypeptide is released after the ribosome encounters a stop codon during
translation termination [8]. Translation is the most energy consuming process in
cells [9] and thus need to be tightly regulated. The most regulated step of translation
is the initiation. Indeed, while only a few factors are dedicated to elongation and
termination, more than 25 proteins are needed to guarantee a proper translation
initiation [10]. Translational regulation can be divided into global regulation of
translation and mRNA specific regulation [11]: global regulation affects the transla-
tion efficiency of most mRNAs through a general tuning of translation, while mRNA
specific regulation affects the translation of specific mRNAs. Global regulation of
translation is generally mediated through modifications of translation initiation
factors that transform the information from external compartments to the cell.
Notably, translation has been found altered in cancer cells [12, 13]. Indeed, recent
works have shown that the translational machinery plays an active role in transfor-
mation and tumor malignancy, suggesting that it can be a therapeutic target [14,
15].
Eukaryotic Initiation Factor 6 (eIF6)
Eukaryotic Initiation Factor 6 (eIF6), also known as integrin β4 binding protein
or p27BBP, is a unique conserved protein, with no motifs shared with other proteins.
The protein is 245 aminoacids long and displays a striking 95% identity between its
3human and Drosophila homologs [16]. The structure of eIF6 was resolved by X-ray
cristallography [17]: eIF6 is a higly rigid protein, organized with a cyclic fold known
as pentein or star-like structure (Figure 1). This cyclic structure is made by five
stretches of α/β subdomains arranged to form a five-axis pseudosymmetry. Inside
this structure, sixteen well ordered water molecules are hosted, with limited motility.
Figure 1: Structure of eIF6. The protein has a unique star-like structure known as
pentein, formed by five quasi-indentical subdomains (from A to E) arranged in a
pseudosymmetry
It has been demonstrated that eIF6 binds the large subunit of the ribosome, 60S,
in the intersubunit space, and it is also able to interact with the C-terminal chain of
the ribosomal protein L23 (rpL23) [18]. In addition to rpL23, to help the binding
between eIF6 and the 60S, eIF6 also interacts with the sarcin loop of rpL24. Due to
its position in the intersubunit space, that causes a steric hindrance, the binding
of eIF6 to the 60S prevents its joining with the small ribosomal subunit, the 40S.
Actually, eIF6 was first identified for its anti-association activity in calf liver [19]
and in wheat germ [20]. It is therefore reasonable hypothesize that eIF6 activity
is relevant for translational control. Then, if eIF6 prevents the joining of the two
ribosomal subunits, to starts translation eIF6 needs to be released from the 60S. For
this event, two models have been proposed (Figure 2):
• After the traslocation from the nucleus to the cytoplasm of the complex eIF6-
60S, the interaction with the Shwachman-Bodian-Diamond Syndrome protein
4Figure 2: Models of eIF6 release from the 60S and subsequent initiation of translation. A)
Interaction of the complex eIF6-60S with SBDS and Efl1p leads to a conforma-
tional change that causes the release of eIF6 from the 60S. B) Activated PKC
interacts with RACK1, on the 40S. PKC phosphorylates eIF6 on its C-terminus,
determining a conformational change and the consequent release. Adapted from
[26] (A) and from [27] (B).
(SBDS) and the GTPase Efl1p leads to the allosteric change of the 60S itself
and causes the displacement of eIF6 [21]. This mechanism is relevant to the
maturation of the 60S [22], but it is still unclear if it is also involved in the
translational control.
• Phosphorylation of eIF6 by the PKCβII causes a conformational change in eIF6
itself that leads to its release from the 60S [23, 24]. In this model, activated
PKC translocates from endomembranes and interacts with RACK1, a scaffold
protein docked on the 40S. This complex comes in the vicinity of 60S bound to
eIF6, and PKC phosphorylates eIF6 on its C-terminus, determining the release
[25]. Intriguingly, the C-terminus of eIF6 contains several phosphorylation
sites.
Moreover, besides this anti-association activity, several studies have demonstrated
that, unlike other translation initiation factors, eIF6 has other functions: indeed it
is also necessary for biogenesis of the 60S [27], and therefore is localized both in
the cytoplasm and in the nucleolus. Intriguingly, during evolution eif6 gene has
never been subjected to genetic duplication, strongly suggesting the need of a tight
5regulation of eIF6 protein levels. Indeed, human eIF6 is costitutively expressed in
vitro, but highly modulated in vivo: levels of eIF6 varies among different organs.
Studies on many metazoan tissues demonstrated that the protein is higly expressed
in brain but has low levels in muscles. Furthermore, eIF6 shows high levels in stem
or cycling cells, but is almost undetectable in several post-mitotic cells [28]. These
observations also suggest that it might be difficult to generate in vivo models with
altered levels of eIF6 [29].
eIF6 is upregulated in cancer
Protein synthesis is the most energy consuming process in cell [9] and has
been demonstrated that it largely contributes to gene expression variations [30].
It is reasonable then that it needs to be tightly regulated and that alterations in
translational control could be causative of many pathologies. In particular, it has
been recently uncovered how alterations of gene dosage in both Ribosomal Proteins
(RPs) and translation eukaryotic Initiation Factors (eIFs) are involved in cancer
[31], even if, until a few years ago, alterations to the ribosomal machinery have
been considered only a by-product of transformation and tumor growth rather
than causative of cancer. However, the oncogenic role of an initiation translation
factor, eIF4E, has been known since 1990 [32]. Interestingly, while overexpression of
eIF4E leads to only a mild increase in global translational rate, a specific subset of
mRNAs are more translated in condition of eIF4E increased levels, and these include
oncogenes as c-MYC, anti-apoptotic factors as BCL-xL and proangiogenic factors
like VEGFA [33]. It is no surprise then to find eIF4E levels increased in many cancer
types, such as head and neck, breast, prostate, leukemias and colon [15]. The list of
eIF4E overexpressing cancer is growing continually [34–36]. eIF4E overexpression is
only an example of how cancer cells can benefit from deregulation of gene dosage of
factors involved in translational control, and many other examples could be made.
The role of eIF6 in cancer is less well established. It has been demonstrated that
eIF6 is upregulated or hyperphosphorylated in several cancer types (Figure 3),
6Figure 3: eIF6 is upregulated in colon adenocarcinoma. Adapted from [45]
such as head and neck [37], lung metastasis [38], acute promyelocitic leukemia [39]
and malignant mesothelioma [16, 40]. Moreover, amplification of eif6 gene has
been found in luminal breast cancer [41]. Conversely, it has been observed that
haploinsufficiency of eIF6 results in reduced MYC or HRAS-mediated oncogenic
transformation [42]. Interestingly, MYC-induced lymphomagenesis is strikingly
reduced in murine lymphoma with halved eIF6 levels, resulting in an astonishing
prolonged tumor free survival in the absence of negative side effects [43]. Indeed,
mice haploinsufficient for eIF6 are viable and fertile, even if leaner respect to their
littermates [44]. Still, the mechanism(s) that explain eIF6 overexpression in cancer
remains to be pinpointed, and also the early effects of eif6 increased gene dosage
are still unclear.
Drosophila melanogaster is an outstanding model organ-
ism
Drosophila melanogaster (Figure 4) has been used as a model organism for more
than a century. The first documented use of this organism in a lab dates back to
no less than 1901, in the lab of William Castle, but the undisputed champion of
7Figure 4: Drosophila male and female. It is really easy to distinguish males and females
in Drosophila. Females are slightly bigger, and have a lighter pigmentation.
Genitalia are of course a way to distinguish sexes: Drosophila genitalia are at
the end of the abdomen. Moreover, only males possess a structure known as sex
combs, tiny hair on the legs.
Drosophila research is Thomas Hunt Morgan, who started its pioneering work in
1910 [46]. His studies granted him the Nobel Prize in Physiology or Medicine in
1933, for his discoveries about the role of chromosomes in heredity [47]. Drosophila
was then used to undercover mechanisms of pattern formation [48], development of
the nervous system and even to model human diseases [49]. Drosophila possesses
the main characteristics of all model organisms: a short life-cycle, a simple anatomy,
the ability to produce copious progeny in just few days and it is easy and cheap to
nurture. It is not to understimate that ethical and safety issues are minimal when
using Drosophila.
Like all holometabolous insects, Drosophila undergoes a life cycle made up of
four stages: embryo, larva, pupa and adult (Figure 5). The duration of this life cycle
is strictly dependent on the temperature: development lasts 9 days at 25°C, while at
18°C it proceeds slower. At 25°C, embryos take up rougly a day before hatching in a
larva that eats and grows for over five days, undergoing three moltings. After that,
the larva stops moving and becomes a pupa, that gives rise to an adult through
metamorphosis after four days. This relative short life cycle allows to perform in just
a few weeks genetic experiments that would takes months or even years in zebrafish
8Figure 5: Drosophila life cycle. As every holometabolous insect, Drosophila undergoes four
stages during its life cycle: embryo, larva (with three moltings), pupa and adult.
From the fertilization of the embryo to the adult stage, development lasts nine
days at 25°C.
or mouse. Moreover, each female lay hundreds of eggs during its life, allowing the
generation of a large number of offspring.
Another edge ofDrosophila as a model organism is its powerful genetics. Drosophila
possesses only four pairs of chromosomes and its genome sequence has been released
in March 2000 [50], and it is accessible, together with annotations, via "Flybase" [51].
Among the 14000 estimated Drosophila genes, 75% of disease human genes have been
found [52], legitimating Drosophila also for medical research. In addition to this bulk
of information, there are many genetics tools that can be used in Drosophila. Maybe
one of the most elegant genetic tool used in Drosophila is the GAL4/UAS system
[53] (Figure 6). GAL4 encodes a protein of 881 aminoacids, firstly found in yeast,
that acts as a transcriptional activator upon a genomic sequence, the Upstream
Activating Sequence (UAS), which acts as an enhancer element. In this system,
the GAL4 gene is inserted nearby a promoter, providing a temporal and spatial
9Figure 6: GAL4/UAS system. The yeast transcriptional activator Gal4 can be used to
regulate gene expression in Drosophila by inserting the Upstream Activating
Sequence (UAS) to which it binds next to a gene of interest (gene X). The GAL4
gene has been inserted at random positions in the Drosophila genome to generate
’enhancer-trap’ lines that express GAL4 under the control of nearby genomic
enhancers. Therefore, the expression of gene X can be driven in any of these
patterns by crossing the appropriate GAL4 enhancer-trap line to flies that carry
the UAS–gene X transgene. Adapted from [54].
expression of the protein GAL4. When expressed, GAL4 induces the expression of a
gene that is under the UAS control. This method represents an important tool for
controlled protein expression, both in temporal and spatial manner.
TheDrosophila melanogaster eye and its adult structure
Drosophila melanogaster eye, a stunningly beautiful structure, has been studied
for more than a century, and has been used as a model system to understand
several physiological processes, for example tissue specification, organogenesis, cell
proliferation, specification and differentiation, planar cell polarity and programmed
cell death. From the identification of the first white eyed fly in a sea of wild type
red-eyed flies (Figure 7), this organ has been a favourite model for geneticists, cell
and developmental biologists. In this choice, great importance had the knowledge
that flies can live without eyes. During evolution, two different types of retina
have emerged. Larger animals, including most vertebrates, possess a single camera
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Figure 7: Drosophila adult compound eye. Stereomicroscope images of a wild type (red)
eye and a mutant (white) one. The isolation of a mutant white eye by T. H.
Morgan was groundbreaking in Drosophila research and more generally in the
understanding of hereditariness.
eye, made of three components: a lens, a retina and a pigment layer. This kind
of eye is sensitive and with a high resolving power, but has a major downside:
lens and retina need to have a minimum distance between each other, and this is
why simple camera eyes are presented only by larger animals. Insects and other
smaller animals, instead, present compound eyes, made up of a cluster of identical
units, called ommatidia, each one made of the same components of simple camera
eyes, but compressed and compartimentalized to fit into tiny heads. In spite of
the great difference in appereance between simple and compound eyes, they share
many molecular factors required for their development and their function, so the
initial polyphyletic hypothesis (indipendent appeareance of a structure multiple time
during evolution) was recently excluded.
Drosophila compound eye contains ~800 ommatidia, each one composed of eight
neuronal cells, the photoreceptors (PRCs), named from R1 to R8, photosensitive
cells that transmit visual stimuli projecting directly to the brain. PRCs are capped
by four glial-like, lens secreting cells, the cone cells, and two primary pigment
cells. A hexagonal lattice of secondary and tertiary pigment cells, also known as
InterOmmatidial Cells (IOCs) surround each ommatidium, preventing the passage
11
Figure 8: The retinal determination network (RDN). Members of the RDN are indicated
on a yellow background. Toy activates expression of ey as well as so. Ey activates
expression of so, eya*, optix* and shf*. Eya and So interact to directly activate
expression of their targets: lz, hh, ey and so, as well as indirectly activating
expression of the downstream gene dac. Members of the RDN are required for
eye specification, upstream of photoreceptors specification and differentiation,
with ato functioning to regulate specification of the first photoreceptor cell, R8.
Adapted from [56].
of light between ommatidia. Finally, at every other apex of each ommatidium, there
is another structure, the bristle, a mechanosensory organ [55]. The arrangment of
cells into each ommatidium, and the overall arrangment of ommatidia on the plane
is astonishingly precise, forming a cristalline-like structure. Any perturbation during
development results in the disruption of the structure. This peculiarity, coupled
with the dispensability of the eyes for the flies viability, allowed for the discovery of
a plethora of mutations in genes involved in different aspects of this organization,
such as the number of PRCs, their morphology and function. Indeed, mutations
even only in one gene involved in the development of this structure can cause the
appereance of a easily identified phenotype, known as rough, or also in the complete
absence of the eye.
Overall, the entire ommatidial structure is about 100 µm long. PRCs are
functionally divided in two classes: outer PRCs (from R1 to R6) are important for
motion detection and vision under dim light condition [57]. Inner PRCs instead,
namely R7 and R8, function under bright light condition and are responsible for
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color discrimination. Another major difference between outer and inner PRCs is the
lenght of their projecting axons: outer PRCs have slightly longer axons that span
the entire lenght of the ommatidial structure and project their axons to the lamina,
while inner PRCs are shorter and synapse in the medulla [58]. The light sensitive
organelle is called rhabdomere, and is an elongated apical structure of tightly packed
microvilli [59]. These microvilli harbor the rhodopsins, which are the visual pigments
and that are also required for the building and maintainance of the rhabdomere
structure itself [60]. There are different isoforms of rhodopsin, each one expressed in
different PRCs: all outer PRCs express rhodopsin 1 (Rh1), which detects a broad
wavelenght [61]. In contrast, inner PRCs express a complex pattern of rhodopsins
to maximize the range of wavelenght they can detect. R7 cells express Rh 3 and/or
Rh4, UV-sensitive opsins, while R8 cells can express Rh3 or Rh6, which are instead
green sensitive [62].
Drosophila eye development
Many adult Drosophila organs emerge from larval structures known as imaginal
discs (from the latin word imago, adult insect). The eye is no exception, deriving
from an epithilial monolayer known as the eye-antennal imaginal disc, that gives rise
to most of the Drosophila head structures, from eyes and ocelli of the visual system,
to head epidermis and olfactory organs [63]. The eye imaginal disc derives from
a small subset of cells set aside during embryogenesis, that continue to proliferate
during the three larval stages, while the organism feeds and grows. This proliferation
depends on the action of a network of six transcription factors (ey, toy, optix so, eya,
dac), known as retinal determination factors [64], also active during mammalian eye
establishment (Figure 8). These factors are necessary for both proliferation and cell
fate specification through interaction with many other genes [65]. The knowledge
that the same factors are necessary for the specification of both simple camera and
compound eyes strenghtens the monophyletyc hypothesis for the emergence of eyes
during evolution. Interestingly, the expression of these genes in other imaginal discs
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can drive the development of ectopic eyes.
As said, the eye-antennal imaginal disc gives rise to both eye and antenna. The
factor responsible for the definition of the eye field is eyeless (ey), which expression
is lost during second larval instar from the antennal section of the disc, that is
instead specified by the expression of Cut. ey acts in coordination with other factors
to promote both proliferation and specification of eye fate. During the first two
larval stages cells divide homogeneously. The first sign of differentiation appears
during third larval instar: a physical indentation called Morphogenetic Furrow (MF)
appears at the posterior edge of the eye disc and moves from posterior to anterior
(Figure 9), due to the expression of two morphogenes, Decapentapegic (Dpp), which
is expressed anteriorly of the MF, and Hedgehog (Hh), posteriorly [66]. This physical
indentation is caused by a costriction of the apycal part of the cell and a contration
of the apicobasal axis [67]. Many factors partecipate to this dramatic change in
cellular shape: microtubles, filamentous actin and non-muscle myosin cause the
cells to first enter and then be realesed from this furrow-like state, causing the
posterior-to-anterior sweep of this structure [68]. The MF divides the eye disc in
two disctint regions: anteriorly cells continue to proliferate, while cells in the MF
itself arrest their cell cycle in G1 phase and start their differentiation posteriorly of
the MF. In this wave of differentiation ommatidia are built in a fascinating manner,
one cell at a time, through a network of local signal. The first cell to be specified
is a photoreceptor, R8, through the expression of a basic helix-loop-helix (HLH)
transcription factor, atonal (ato), induced by Hh and Dpp. Loss of ato causes the
complete elimination of PRCs development [69], even if th MF is present and sweeps
the disc [70]. From surrounding undifferentiated cells, specified R8 recreuits stepwise
and pairwise other four PRCs: first R2 and R5, then R3 and R4. At this point,
the five-cell precluster is complete; cells still uncommitted undergo a last mitosis,
known as the second mitotic wave, from which originate all the other cells that put
together an ommatidium. Without the second mitotic wave, differentiation continues
normally, but ommatidia will lack of some cells, hinting that this last round of
14
Figure 9: Differentiation starts after the Morphogenetic Furrow. The MF divides the eye
disc in two disctint regions: anteriorly cells continue to proliferate, while cells in
the MF itself arrest their cell cycle in G1 phase and start their differentiation
posteriorly of the MF. In this wave of differentiation ommatidia are built in
one cell at a time, through a network of local signal, starting from the founder
photoreceptor, R8. During the larva stage, all photoreceptors are specifid,
together with cone cells.
division is necessary only to generate a great quantity of cells [71]. From this point
of view, then it can be said that the first mitotic wave (before the emergence of
the MF) sets the limit of how many ommatidia can be generated, while the second
mitotic wave is responsible of the number of cells that each ommatidium possesses
[72]. Then, from the pool of cells derived from the second mitotic wave, the last three
PRCs are recruited, first R1 and R6, and lastly R7 [73]. The last group of cells that
are committed during the third larval instar is the group of the four non-neuronal,
glial-like cone cells, also known as Semper cells. The main regulator of cone cells
differentiation is DPax2, also known as sparkling, as its mutation causes a glossy
eye, or shaven, for the absence of bristles [74–76]. Although many progresses have
been made in the understanding of how cone cells are recruited and specified, the
exact mechanism(s) is still elusive.
Cone cells are the last cells to be specified during larval stages. The last part
of eye development takes place during pupal stages. The last cells that will be
specified during Drosophila eye development are pigment cells. Although these cells
derive from the second mitotic wave, they are differentiated only during the first
half of the pupal development [77]. As for cone cells, it is still unclear how pigment
15
cells are committed, even though it is now clear that primary pigment cells are
recruited directly by cone cells, though a local signal pathway, dependent on the
secretion of Delta (Dl). Dl is produced in cone cells under the control of the EGF
receptor pathway, then secreted to activate non-autonomously the Notch pathway
in neighbouring cells, that under this signal will differentiate in primary pigment
cells [78]. Still, the transcriptional targets downstream of Notch signal that confer
the primary pigment cell fate remain to be identified. However, this pathway is not
sufficient to trigger primary pigment cells specification per se. Cells that will become
primary pigment cells must also express a trascription factor belonging to the RUNX
family, Lozenge, in order to be correctly committed [78]. In addition, other factors
have a role in this determination: trascription of many genes necessary in this event
is controlled by the retinal determination factors Eyes absent (Eya) and Sine Oculis
(So) [79]. The last cells that will be specified are secondary and tertiary pigment
cells. The factors necessary for this last cell fate commitment are still more evasive
than the ones necessary for primary pigment cells, even if now the role of Notch and
EGF Receptor pathways have been demonstrated [80–82]. During this last event
of cell fate commitment, a wave of spatially restricted programmed cell death is of
great importance to determine the right cristal-like structure of the fly retina.
The apoptotic wave during pupal stages determines the
cristalline structure of Drosophila eye
Apoptosis has many roles during development of all metazoan. These include the
elimination of cells and tissue that are obsolete, the removal of aberrant cells that
could potentially be harmful to the organism and the generation of complex tissue
architecture [83]. During Drosophila eye development, the precise adult structure
is obtained also through a wave of Programmed Cell Death (PCD) that during
pupal stages sweeps the developing retina to eliminate cells in excess produced by
the second mitotic wave [82]. Whethever the signals that lead to the recognition
16
Figure 10: Apoptosis shapes the pupal retina. During pupal stages, apoptosis of IOCs
determines the right number of cells for each ommatidium. In A), wild type
retina at 48 hours APF, in B) at 24 hours APF. Adapted from [98].
of which cells need to be removed is, once the apoptosis is triggered it inevitably
results in the death of the cell [84], and the key players are the same involved in
mammalian apoptosis. In Drosophila, two initiator (or upstream) caspase have been
identified, Dronc and Dredd [85–87]. It has been demonstrated that Dronc is active
during pupal PCD [88] and that, similarly to its mammalian counterpart caspase 9,
it forms a complex with the fly orthologue of Apaf-1 Dark [89, 90]. The activation
of Dronc leads to the subsequent activation of Drice and Dcp-1, the downstream
caspases active in the pupal IOCs [88]. The activity of these caspases is inhibited
by the direct binding of DIAP-1 [91]. Other factors are involved in this process,
such as the main proapoptotic factors in Drosophila, the RHG proteins consisting
of Reaper (Rpr), Head involution defect (Hid) and Grim [92]. These factors’ levels
are regulated by several upstream signals such as stress, developmental cues or the
steroid hormone ecdysone [93–95]. The main role of RHG proteins is to bind to
the Drosophila inhibitor of apoptosis protein (Diap1), which is essential for keeping
caspases inactivated in the absence of apoptotic stimuli [96]. When Diap1 is bound
by RHG proteins, the apoptotic inhibitor itself is ubiquitinated and consequentely
degradated, thus alleviating the block on caspases to allow Dronc and downstream
caspase activation [97].
After specification of the primary pigment cells, the remaining Interommadial
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Cells (IOCs) are arranged on the plane in two or three rows around ommatidia.
Then, these cells arrange themeselves in a single row, favouring contact with the
primary pigment cells [77, 99]. This arrangement is mediated by two genes: roughest
and hibris, the first expressed in IOCs, the latter in primary pigment cells. The
protein products of these two genes are members of the Neph/Nephrin family [100,
101], that mediates calcium-indipendent cell-cell adhesion [102, 103]. Roughest
protein localizes in IOCs specifically at the interface with the primary pigment cells,
while Hibris is likely localized in adherens junction of primary pigment cells [104].
These evidences suggest that Roughest and Hibris directly interact, and that this
interaction is essential for the arrangement of IOCs during pupal developmental
stages. After the conclusion of this sorting process, two to three cells are in excess
and need to be removed. The removal of these cells is obtained through a spatially
restricted wave of PCD [105] (Figure 10). The accepted model for the identification
of cells in excess is that IOCs compete for a limiting survival factor. The sorting
of IOCs cells is then necessary to allow this limiting survival factor to be unevenly
distributed only in the right number of cells, and this is achieved through differential
adhesion. Studies using direct ablation of specific cellular subtypes shed some light to
what is the limiting survival factor. Indeed, direct ablation of photoreceptors had no
effect on the death of IOCs, while specific removal of both cone and primary pigment
cells resulted in the apoptosis of neighbouring IOCs [106]. Cone and primary pigment
cells then are the cellular subtypes that send a survival signal to neighbouring IOCs.
This signal was identified in Spitz, a EGF Receptor ligand. Then, IOCs express
EGF Receptor, and those IOCs that are near enough to receive Spitz will survive.
Notably, the activation of the EGF Receptor pathway results in the inhibition of
Hid, which is, among the RGH proteins, the major inhibitor of DIAP during the
pupal apoptotic wave [88]. These finding are also supported by the observation of
induction of ectopic cell death upon EGF Receptor pathway inactivation [107, 108].
As in all Drosophila eye development, this event is not controlled by a single signal
pathway, but by a network of signalling, in a fine balance of agonistic and antagonistic
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signals. Indeed, cone and specified secondary and tertiary pigment cells secrete Argos,
a repressor of EGF Receptor [109], and it was observed that overexpression of Argos
causes increased apoptosis [108, 110]. The fact that already specified secondary and
tertiary pigment cells secrete Argos is consistent with a model in which cells fated to
survive ensure the destruction of their neighbouring, still uncommitted cells. There
is also a second antagonistic signal, mediated by the Notch pathway. Mutations
in notch result in less cells undergoing apoptosis [55]. Interestingly, loss of Notch
causes the uniform distribution of Roughest in IOCS [111], and that results in the
block of IOCs sorting.
Ecdysone is a steroid hormone essential for Drosophila
development
Steroid hormones regulate different events in all higher eukaryotes, such as
development, reproduction and metabolism [112]. The fact that regulation of many
and different biological phenomena has been conserved from insects to humans
suggests the importance of steroids in all metazoan. Drosophila melanogaster offered
an outstanding model to study regulation of steroid hormones valid also for higher
organisms. This is true for several reasons: as already said, Drosophila possesses all
the useful characteristics of a model organism, such as a short life cycle, a sequenced
genome and powerful genetic tools. Moreover, Drosophila presents giant polytene
puffs in chromosomes of the salivary glands in response to ecdysone, the master
regulator steroid hormone of development in Drosophila. Interestingly, ecdysone is
homologous to mammalian steroid hormones such as estradiol (Abolaji et al. 2013).
As already said, Drosophila development lasts 9 days at 25°C, and, as in all
holometabolous insect, consists of embryonic, three larval stages, prepupal, pupal
and lastly adult (Figure 8). Each one of these stage is punctuated by a ecdysone
pulse [113] (Figure 11). In the hemolymph, many forms of ecdysone can be found,
but the one that is biologically active is the 20-hydroxyecdysone (20-HE) [114]. The
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Figure 11: Ecdysone pulses during Drosophila development. Each developmental transition
is punctuated by its own 20-HE pulse, each one with unique characteristc such
as amplitude and duration, that triggers moltings and metamorphosis.
mechanism of action of 20-HE, as other lipofilic hormones, is the binding to a nuclear
receptor and the consequent induction of a small subset of early genes, that are
trancription factors. These early genes in turn induce the transcription of a larger
subset of genes, known as late response genes, that are the ultimate responsible
for the developmental changes required for metamorphosis. This paradigm is also
known as the Ashburner model, from the seminal work of Michael Ashburner in
1974 [115].
As said, each developmental transition is punctuated by its own 20-HE pulse, each
one with unique characteristc such as amplitude and duration. Ecdysteroids are
produced in the protoracic gland, a part of a neuroendocrin organ called ring
gland. The protoracic gland secretes a precursor, then every tissue takes up this
precursor and converts it in the active form, the 20-HE [116]. 20-HE is produced,
as many other steroid hormones, using cholesterol as a precursor [117], which is
imported in the protoracic gland by Npc1a [118]. The human homologue of this
genes, when mutated, causes a fatal neurodegenerative disorder, the Niemann-Pick
Type C Disease, where cholesterol accumulates in lysosome [119]. The conversion
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Figure 12: Ecdysone biosynthetic pathway. Biosynthesis of ecdysone takes place for the
most part in the protoracic gland. The starting precursor is cholesterol, and
from that a series of enzymatic reactions transforms it in ecdysone. This
hormone then is secreted and every target tissue takes it and transforms it,
with a final enzymatic reaction, in 20-HydroxyEcdysone.
from cholesterol to ecdysone starts with a Rieske electron oxygenase, Neverland
(nvd), which generates 7-dehydrocholesterol [120]. After this first enzymatic reaction,
7-dehydrocholesterol is converted in 5-βketodiol, in a series of reactions of which
little is known, and thus this step is called the black box. Enzymes believed to act in
this part of the pathway are Shroud (a short-chain dehydrogenase/reductase), and
two cytochrome P450 enzymes, Spookier and Cyp6t3 [121]. Other three cytochrome
P450 enzymes carry out the last part of the biosynthetic pathway, namely Phantom,
Disembodied and Shadow, then the ecdysone thus produced is secreted from the
protoracic gland and finally transformed in its active form, 20-HE, in the target
tissues, by Shade (Figure 12). These last four genes are colletively known as the
Halloween genes [122].
The nuclear receptor that binds 20-HE is a heterodimer composed by Ecdysone
Receptor (EcR) and Ultraspiracle (USP) [123]. The vertebrate homologue of USP
is RXR [124]. Three isoforms of EcR have been identified: A, B1 and B2, with
common motifs for the DNA and ligand, but with unique amino-termini [125]. Every
isoform is expressed in different tissues and developmental stages, and each one
is responsible for different ecdysone-induced events [125]. Three genes have been
identified as early genes: BR-C, E74 and E75 [126, 127] [127], they encode for
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transcription factors and, as predictable, their mutations is larval lethal, consistently
with their role in metamorphosis [128]. The proteic products of these three genes
are able to induce the transcription of many late genes, the actual effector of the
metamorphosis. Interestingly, among events dependent on ecdysone, one of the
most studied is apoptosis, necessary to destroy tissues that have become obsolete
with metamorphosis. Ecdysone induces apoptosis through upregulation of the
apoptosome components dark and dronc as well as drice [129]. Also other death
genes are induced by high titre of ecdysone: the early response genes BR-C and
E74 promote transcription of rpr and hid, two of the main proapoptotic factors
in Drosophila [92], while downregulating the expression of the apoptosis inhibitor
diap1 (Kilpatrick et al., 2005). rpr and dronc are also direct targets of the EcR-USP
complex [130].

Outline of the Thesis
Ribosomal machinery and/or translational control have been found altered in
cancer cells. In particular, it has been recently uncovered how alterations of gene
dosage in both Ribosomal Proteins (RPs) and translation eukaryotic Initiation
Factors (eIFs) are involved in cancer, even if, until a few years ago, alterations to
the ribosomal machinery have been considered only a by-product of transformation
and tumor growth rather than causative of cancer. Among IFs found altered in
tumours there is the Eukaryotic Initiation Factor 6 (eIF6), which regulates both
ribosome biogenesis and translation initiation. It has been demonstrated that
eIF6 haploinsufficiency protects mice from lymphomagenesis without adverse effects.
Moreover, eIF6 has been found upregulated in many cancers types, such as colorectal,
prostate, lung, leukemias and mesothelioma. In luminal breast cancer, eif6 gene locus
has been found amplified. The eif6 gene is a single genetic locus highly conserved
from yeast to humans, that has never been subjected to genetic duplication, strongly
indicating the necessity of a tight regulation of its gene dosage. However, an in
vivo study that deeply understand the early events associated with increased levels
of eIF6 is still lacking. Thus, to address this issue, we applied the power of easy
genetics and imaging offered by the Drosophila melanogaster model. Therefore, we
genetically increased the levels of the Drosophila homologue of eIF6, DeIF6, and we
deeply characterized the first in vivo model with high levels of DeIF6. We decided
to restrict DeIF6 overexpression only in the fly eye because we found that increasing
DeIF6 in the whole organism resulted in early lethalithy, a feature quite expected.
We found that increasing DeIF6 levels results in a higher general translational
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rate and in a rough eye phenotype dependent on an aberrant apoptosis during
development. We also found that, mechanistically, eIF6 reshapes transcription and
histone acetylation, disrupting a hormonal pathway, the ecdysone network. This
work is the first evidence of how increased translation generates a full transcriptional
and hormonal deregulation, providing new perspectives on treating cancer cells with
altered eif6 gene dosage.
Results
DeIF6 overexpression results in a rough eye phenotype
The human (p27BBP/eIF6) and Drosophila (DeIF6) homologues share 95% iden-
tity [16]. We decided to take advantage of this high similarity to study the early
effects of eIF6 overexpression using the Drosophila model. First, we overexpressed
DeIF6 in Drosophila during early development, using the ubiquitous driver TubGAl4.
Figure 13: Overexpression of DeIF6 using the ubiquitous driver TubGAL4 resulted in late
embryonic lethality
This overexpression resulted in early embryonal lethality, thus confirming the
necessity for a tight regulation of eIF6 gene dosage (Figure 13). To overcome the
problem of early lethality, we then focused our studies on a dispensable organ, the
eye. We overexpressed DeIF6 only in the fly eye using the GMRGAL4 driver, and
obtained an adult eye with altered morphology, also known as rough eye (Figure 14
a-b). We further characterized this phenotype, using Scansion Electron Microscopy
(SEM), observing that the precise structure of the eye was completely disrupted upon
DeIF6 overexpression, with flattened ommatidia and bristles arranged randomly
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on the plane (Figure 14 c). Moreover, analysis of semithin tangential sections
demonstrated that the roughness was not due to loss of photoreceptors, that were
present and in the correct number, but to a completely aberrant arrangement of
cells (Figure 14 c).
Figure 14: Overexpression of DeIF6 in the fly eye results in a rough phenotype:
a. Stereomicroscope images of GMRGAL4/+ and GMR>DeIF6 showing the
rough eye phenotype when DeIF6 was overexpressed. b. Representative western
blot showing the levels of DeIF6 in GMRGAL4/+ and GMR>DeIF6 adult eyes.
c. Representative SEM images of GMRGAL4/+ and GMR>DeIF6 adult eyes,
which show the aberrant morphology exhibited by overexpressing eyes, with
flattened ommatidia and randomly arranged bristles. Scale bars, in order, 10µm,
5µm and 2,5µm.d. Representative semithin tangential sections of GMRGAL4/+
and GMR>DeIF6 adult eyes. Photoreceptors are present and in the correct
number, but cells’ arrangment on the plane is lost. Scale bar 10µm
Increased DeIF6 gene dosage results in increased puromycin
incorporation
eIF6 is a translation initiation factor involved in both biogenesis of the large
subunit of the ribosome, the 60S, and in the control of initiation of translation, by
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binding the 60S itself and preventing premature joining with unloaded 40S. Thus,
we asked what happened to translation when eIF6 gene dosage was increased. To
this end, we first evaluated the functionality of the ectopic protein, by assessing
its ability to bind the 60S. Using an assay recently developed in our lab, the iRIA
(Pesce et al. 2015), we observed a 25% reduction of free 60S sites when compared
to control (Figure 15 a). This reduction in 60S free sites indicated that the ectopic
expressed DeIF6 was able to bind the 60S, i.e. was functional. Next, we measured
translational levels in eye imaginal discs using a modified SUnSET assay. In this
assay, we treated eye imaginal discs ex vivo with puromycin, an analogue of a
aminoacylated-tRNA, that is incorporated in protein nascent chains by ribosomes.
Incorporated puromycin, thus, is an indicator of protein synthesis. We observed
a two-fold increase in incorporated puromycin in eye imaginal discs upon DeIF6
overexpression, when compared to control (Figure 15 b-c).
To evaluate wheter this increase in puromycin incorportation was specific to
Drosophila, or a more general effect of eIF6 increased levels, we overexpressed the
human isoform of the initiation factor in HEK293 cells(Figure 16 a), and measured
puromycin incorporation in condition of serum stimulation. Again, we observed
a two-fold increase in puromycin incorporation, measured with a cytofluorimeter
(Figure 16 b-c). Taken together, our biochemical analyses reveal that overexpressed
DeIF6 is functional, and that its overexpression causes a conserved increase in general
translation.
DeIF6 overexpression impairs apoptosis during pupal de-
velopment
To understand how deregulation of general translation could lead to morphological
defects such as the ones observed upon DeIF6 overexpression in the adult fly eye,
we thoroughly analyzed eye development. The first developmental stage that we
analyzed was the third larval instar, since the driver we used, the GMRGAL4, starts
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Figure 15: High levels of DeIF6 result in increased puromycin incorporation. a.
iRIA assay demonstrates that ectopic expressed DeIF6 is able to bind the 60S. b.
Quantification of SUnSET assay with ImageJ software. Graph represents mean
± SD. Statistic applied was t-test, paired, two tails. Experiments were performed
at least three times. c. Representative immunofluorescence experiment of
SUnSET assay, showing the two-fold increase in puromycin incorporation upon
DeIF6 overexpression. Scale bar 10µm
to be expressed at this stage. We observed no differences neither in morphology nor
in cell identities upon DeIF6 overexpression, when compared to control (Figure 17
a-c). More in details, we analyzed several markers in third larval instar eye imaginal
discs: to identify neuronal cells we stained for ELAV, for cone cells we used Cut,
while for R2/R5 photoreceptors we used Rough. All these cellular markers revealed
no differences upon DeIF6 overexpression.
Next, we analyzed the effect(s) of DeIF6 overexpression in pupal development
(Figure 18). Again, we stained for ELAV/Cut markers, finding that cells continued to
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Figure 16: Increased puromycin incorporation driven by eIF6 overexpression
is conserved also in mammalian cells. a. Representative western blot
demonstrating eIF6 overexpression in HEK293 cells. b. Quantification of
SUnSET assay with ImageJ software. Graph represents mean ± SD. Statistic
applied was t-test, paired, two tails. Experiments were performed at least three
times. c. Representative dot plot of citofluorimetry experiment of SUnSET
assay in HEK293 cells showing overexpressing and control populations
maintain their identities and were present in the correct number, but their arrangment
on the plane of the tissue was disrupted upon DeIF6 overexpression at 40 hours
After Puparium Formation (APF) (Figure 18 b). To further confirm this phenotype,
we also stained for another morphological marker, chaoptin, which localizes on
the membranes of photoreceptors. We observed that GMRGAL4/+ pupal retinae
presented the typical pattern for chaoptin, showing all eight photoreceptors on a single
plan, while DeIF6 overexpressing retinae did present all eight photereptorial cells,
but never on the same focal plane (Figure 18 c). In addition to this intraommatidial
defect, we also observed that ommatidia lost their neat columnar arrangement on
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Figure 17: Cell identities and tissue morphology are preserved in larval eye
imaginal discs upon DeIF6 overexpression. a. Immunofluorescence
staining for DeIF6 to confirm the overexpression of the protein in the lar-
val developmental stage. b. GMRGAL4/+ and GMR>DeIF6 eye imaginal
discs stained for a neuronal (ELAV) and a cone (Cut) marker demonstrate
that both cell types maintain their identity. c. Rough staining, specific fo
R2/R5 photoreceptors, presents the same pattern for both GMRGAL4/+ and
GMR>DeIF6
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Figure 18: DeIF6 overexpressing mid-pupal retinae present aberrant morphol-
ogy but preserved cell identities. a. Immunofluorescence staining for
DeIF6 to confirm protein overexpression during pupal stage. b. GMRGAL4/+
and GMR>DeIF6 40 hours APF retinae stained for ELAV and Cut demon-
strate that both cell types maintain their identity but cells present an incorrect
arrangment on the plane when DeIF6 levels are increased. c. Chaoptin stain-
ing, specific for intra-photoreceptors’ membranes, show the aberrant intra- and
interommatidial morphology associated with DeIF6 overexpression Scale bar
10 µm
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the plane upon DeIF6 overexpression. Taken together, these morphological analyses
strongly evidence that DeIF6 overexpression has no effect on cell identities, but
rather disrupts their arrangement on the epithelial plane.
Among fundamental events that occur during pupal development and that control
ommatidial morphology there is a wave of Programmed Cell Death (PCD), that
sweeps the fly retina from 25 to 42 hours APF. We then decided to analyze PCD in
our model. Interestingly, TUNEL assay performed at 28h APF showed that DeIF6
overexpressing retinae did not present apoptotic nuclei, conversely to control retinae
(Figure 19 a).
The analysis of TUNEL (Figure 19 b) and of the Drosophila effector caspase, Dcp-1,
at 40 hours APF (Figure 20 a), revealed again an intriguing absence of apoptotic
cells in DeIF6 overexpressing retinae when compared to wild type ones. Interestingly,
we observed Dcp-1 positive cells in GMRDeIF6 retinae only later in development, at
60 hours APF (Figure 20 b). At this developmental time, wild type retinae did not
show any Dcp-1 positive cell, confirming the end of the PCD in this developmental
window. We quantified the number of Dcp-1 positive cells in both time points
analyzed, revealing a striking 75% reduction at 40 hours APF in condition of high
levels of DeIF6, and an 80% reduction at 60 hours APF (Figure 20 c).
We also performed another immunofluorescence experiment, by staining retinae
with Armadillo, the Drosophila β-catenin homologue, that localizes on membranes
of cells surrounding photoreceptors, thus giving an indication of their number. We
found, at 40 hours APF, that GMRGAL/+ retinae presented the expected Armadillo
pattern, while DeIF6 overexpressing retinae showed the presence of extra-numerary
cells around the ommatidial core (Figure 21 a, cells in excess indicated with ∗). We
quantified the number of cells per ommatidium, finding that ommatidia of DeIF6
overexpressing retinae possessed 15 cells, roughly 30% more than their wild type
counterpart (Figure 22 a). Conversely, at 60 and 72 hours APF, while GMRGAL4/+
retinae continued to show the expected Armadillo pattern, the Drosophila β-catenin
homologue was no longer detectable in DeIF6 overexpressing retinae (Figure 21 b
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Figure 19: PCD is delayed when DeIF6 levels are higher than normal. TUNEL
assay at 28 hours APF (a. and 40 hours APF b. in GMRGAL4/+ and
GMR>DeIF6 show that PCD is blocked in these developmental stages upon
DeIF6 overexpression. Scale bar 50 µm
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Figure 20: Increased deif6 gene dosage results in delayed and increased PCD.
a. Dcp-1 staining 40 hours APF. GMRGAL4/+ presents Dcp-1 positive cells,
i.e. dying cells, while GMR>DeIF6 does not present any Dcp-1 positive cell,
indicating a block in PCD b. 60 hours APF GMRGAL4/+ retinae do not show
any Dcp-1 positive cell, indicating that PCD is concluded at this developmental
stage. Conversely, GMR>DeIF6 retinae show Dcp-1 positive cells, indicating
a delay of PCD. c. Quantification of Dcp-1 positive cells demostrates first
a block and then an increase in the number of apoptotic cells upon DeIF6
overexpression. Scale bar 10 µm. Statistic applied was t-test, paired, two tails.
Experiments were performed at least three times.
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and 22 b). Then, with Armadillo staining we obtained another hint that PCD was
first blocked and then aberrant upon DeIF6 overexpression. Taken together, these
results demonstrate that the first effect of eIF6 overexpression is a strong delay in
the onset of PCD, which might be the cause of the rough phenotype.
Figure 21: Cell number is altered when DeIF6 is overexpressed. a. 40 hours APF
retinae stained for Armadillo, the Drosophila β-catenin homologue, showing the
presence of extranumerary cells (indicated as ∗) when DeIF6 is overexpressed.
b. 60 hours APF retinae stained for Armadillo. GMRGAL4/+ retinae continue
to present the expected pattern while GMR>DeIF6 retinae show the loss of
cells around ommatidia. Scale bar 10 µm.
36
Figure 22: Alteration of cell number during pupal stage upon DeIF6 overexpres-
sion. a. Comparison of cell number around each ommatidium in the two geno-
types, GMRGAL4/ and GMR>DeIF6, showing an increase in GMR>DeIF6
respect to control. b. Late pupal stage (72 hours APF) retinae stained for
Armadillo show the loss of cells around ommatidia upon DeIF6 overexpression
Scale bar 10 µm.
Overexpression of DeIF6 in specific cellular subtypes is
sufficient to cause a rough eye through PCD alteration
PCD during pupal development is dependent on the crosstalk between two
cell types: cone cells and Inter Ommatidial Cells (IOCs). Thus we overexpressed
DeIF6 in either one of these two cell types, with the spaGAL4 or 54CGAL4 drivers
respectively. The overexpression here resulted in a rough eye phenotype, albeit
milder with respect with the one obtained with the GMRGAL4 driver (Figure 23).
We then characterized spaGAL4 rough eye, and we observed, with tangential
semithin sections, that also with this driver the structure of the compound eye
was lost but photoreceptors were present and in the correct number (Figure 24 a).
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Figure 23: Increasing deif6 gene dosage specifically in cone and interommatidial
cells is sufficient to cause a rough phenotype. Stereomicroscope images
of spa>DeIF6 and 54C>DeIF6 eyes, showing that the overexpression of DeIF6
only in cone and interommatidial cells repectively is sufficient to cause in a
rough phenotype.
Analyzing pupal development, we observed the neat DeIF6 overexpression only in
cone cells (Figure 24 b), and again the disrupment of the arrangement of cells on
the plan even though their identities were maintained (Figure 24 c). Moreover, we
confirmed the absence of Dcp-1 positive cells upon DeIF6 overexpression restricted in
cone cells, when compared to control at 40 hours APF (Figure 25 a). Dcp-1 apoptotic
nuclei were instead present at 60 hours APF in cone cell DeIF6 overexpressing retinae,
in the same temporal pattern presented by GMRGAL4 overexpressing retinae (Figure
25 b). To further confirm that PCD was responsible for the rough eye observed when
overexpressing DeIF6 in all cells of the eye, or only in cone cells or IOCs, we blocked
apoptosis by co-expressing DeIF6 with the Baculovirus caspase inhibitor p35, under
the control of the GMRGAL4 driver. Intriguingly, we observed an almost complete
rescue of the rough eye (Figure 26). Taken together, these data suggest that altered
PCD is likely responsible for the rough eye phenotype.
Developmental defects associated with increased DeIF6
levels are not tissue specific
Once determined that DeIF6 overexpression in the eye correlated with increased
general translation and delayed PCD, we asked whether such defects were organ
specific or a more general effect of DeIF6 high levels. To answer this question, we took
38
Figure 24: Characterization of rough phenotype of spa>DeIF6 flies. a. Rep-
resentative tangential sections of spaGAL4/+ and spa>DeIF6 showing the
disrupted structure upon DeIF6 specific overexpression in cone cells. b. Mid-
pupal retinae stained for eIF6 to confirm that overexpression of the protein
is restricted to cone cells. c. Mid pupal stage retinae stained for ELAV and
Cut confirm that neuronal and cone cells identities are maintained but their
arrangement on the plane is lost.
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Figure 25: spa>DeIF6 presents the same apoptotic defect of GMR>DeIF6. a.
Dcp-1 staining 40 hours APF. spaGAL4/+ presents Dcp-1 positive cells, i.e.
dying cells, while spa>DeIF6 does not present any Dcp-1 positive cell, exactly
as GMR>DeIF6 mid-pupal retinae. b. 60 hours APF spaGAL4/+ retinae
do not show any Dcp-1 positive cell, indicating that PCD is concluded at this
developmental stage. Conversely, spa>DeIF6 retinae show Dcp-1 positive cells,
indicating a delay of PCD
advantage of another Drosophila driver, the MSGAL4, which overexpresses its UAS
target only in the dorsal wing disc. We observed that the wings overexpressing DeIF6
presented a completely shattered structure (Figure 27 a). In addition, SUnSET assay
on wing imaginal discs revealed again a two-fold increase in puromycin incorporation
upon DeIF6 overexpression (Figure 27 b-c). We also observed a dramatic increase
in Dcp-1 positive cells, i.e. cells undergoing apoptosis, in the dorsal portion of
the wing imaginal disc, specifically where DeIF6 is overexpressed (Figure 27 d).
Taken together, these results indicate that DeIF6 increased levels are detrimental
in developing tissues by a pronounced increase in both general translation and
apoptosis.
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Figure 26: Apoptosis is responsible of the rough phenotype. a. Representative
stereomicroscope images of GMR>DeIF6;p35 and GMR>DeIF6 adult eyes. b.
Western blot of DeIF6 levels in GMR>DeIF6;p35 and GMR>DeIF6. For each
genotype, densitometric ratio (DeIF6/β-catenin) was calculated with ImageJ.
Gene expression analyses reveal a transcriptome rewiring
that results in altered ribosome maturation and ecdysone
signalling
We assessed that increased DeIF6 gene dosage resulted in increased translation
and apoptosis, in a tissue unspecific manner. We then asked if DeIF6 increased gene
dosage was also able to induce transcriptional changes. To this end, we performed
two indipendent RNASeq experiments, by comparing eye imaginal discs and 40
hours APF pupal retinae of GMRGAL4 and GMR>DeIF6 genotypes (Figure 28).
Interestingly, we observed, in both developmental windows analyzed, a common
trend for several gene sets, including a common upregulation of genes related to
ribosome biogenesis upon DeIF6 overexpression (Figure 28 a). Strikingly, our GSAA
analysis revealed that also the rRNA processing subsets were upregulated. These
observation strongly point to a role of ribosome biogenesis inducer for eIF6. In our
gene expression analysis we also found confirmation to our experimental conclusions:
indeed, we found an upregulation of genes related to apoptosis and PCD in our
overexpressing pupal samples (Figure 28 a,c). On the other hand, mRNAs encoding
specialized eye enzymes, such the ones responsible for pigments biosynthetic pathways,
were downregulated upon DeIF6 overexpression. These observations were consistent
with altered eye morphology. Intriguingly, the most changed genes associated with
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Figure 27: Developmental defects induced by deif6 increased gene dosage are
not tissue specific. a. Representative stereomicroscope images ofMSGAL4/+
and MS>DeIF6 adult wings, showing the complete shuttered structure of the
wing overexpressing DeIF6. b. SUnSET assay quantification by ImageJ show
a two-fold increase in puromycin incorporation upon DeIF6 overexpression
in wing imaginal discs, consistent with results obtained in eye imaginal discs.
Graph represents mean ± SD. Statistic applied was t-test, paired, two tails.
Experiment was performed at least three times. c. Representative SUnSET
assay performed through immunofluorescence, indicating the two-fold increase in
puromycin incorporation. For each genotype, two magnifications are compared:
63x (scale bar 50 µm) and 252x (scale bar 10 µm). d. Apoptosis is increased
in wng imaginal discs overexpressing DeIF6. Wing imaginal discs stained for
Dcp-1 and DeIF6 in control (MSGAL4/+) and DeIF6 overexpressing imaginal
wings (MS>DeIF6 ) showing the striking increase of apoptotic cells upon DeIF6
overexpression.
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DeIF6 overexpression all belonged to one specific pathway, the ecdysone pathway.
Indeed, when DeIF6 was overexpressed we found a striking downregulation of
many genes involved in the biosynthesis of the steroid hormone active form, 20-
HydroxyEcdysone (20-HE). For example, we found that nvd, phm and sad were
almost absent in DeIF6 larval overexpressing samples, and also genes belonging to
the early (rbp) and late (ptp52f ) ecdysone signalling cascade were downregulated
as well (Figure 28 a-b). Thus, we can conclude that DeIF6 overexpression leads
to an overall silencing of the ecdysone pathway. In addition, we found that gene
sets related to chromosome organization were upregulated in GMR>DeIF6 samples,
suggesting a possible role of the initiation factor on epigenetics. For this reason, we
analyzed the enzymatic activity of Histone Deacetylases (HDACs), which remove
acetyl groups from histones. We found an interesting two-fold decrease of HDACs
activity (Figure 28 d) when analyzing DeIF6 overexpressing adult eyes, compared
to control. Interestingly, it has already been demonstrated that transcription of
ecdysone biosynthetic enzymes is strictly under the control of epigenetics. Overall, our
data provide a potential causal link between translation and control of transcription,
demonstrating that overexpression of DeIF6 correlates with silencing of ecdysone
signalling and reduction of HDACs activity.
Ecdysone administration partially rescues the adult phe-
notype
Gene expression analysis strongly pointed to a silencing of ecdysone signalling
upon DeIF6 overexpression. Thus, we asked whether the shutdown of this hormonal
pathway could be responsible for the observed GMR>DeIF6 phenotype. To address
this issue, we administered 20-HE to third instar larvae, and analyzed apoptosis at 40
hour APF and adult morphology. Strikingly, we observed that 20-HE administration
led to a partial rescue of the apoptotic defect. Indeed, staining for Dcp-1 at 40 hours
APF showed the precence of apoptotic cells in GMR>DeIF6 retinae treated with
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the active form of the hormone, which were instead absent in not treated DeIF6
overexpressing control (Figure 29 a). Consistently, also adult eyes of GMR>DeIF6
treated with 20-HE showed a partial rescue of the rough phenotype (Figure 29 b).
More in detail, upon DeIF6 overexpression eyes were 30% smaller than control.
Instead, when treated with the hormone, the adult eye observed was 20% larger than
untreated control, even if still rough and smaller than GMRGAL4/+ eyes. These
data strongly indicate that the overall reduction in ecdysone signalling causes the
apoptotic and morphological defects observed upon DeIF6 overexpression.
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Figure 28: Gene expression analyses show a transcriptional rewiring and the
downregulation of ecdysone pathway. a. Venn diagram showing genes
differentially expressed in GMR>DeIF6 eye imaginal discs and mid-pupal
stage retinae respect to control (GMRGAL4/+). b. Heat Map representing
absolute gene expression levels in GMR>DeIF6 and GMRGAL4/+ eye imaginal
disc samples for the gene set of ecdysone biosynthesis by Gene Ontology,
showing the striking shut off the ecdysone biosynthetic pathway upon DeIF6
overexpression. c. Heat Map representing absolute gene expression levels in
GMR>DeIF6 and GMRGAL4/+for the subset of genes involved in PCD and
Eye Developmnet in pupal samples, showing the upregulation of these genes
upon DeIF6 overexpression. d. Representative graph showing lower HDACs
activity in association with high DeIF6 protein levels. The assay has been
performed on adult heads protein extracts.
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Figure 29: 20-Hydroxy-Ecdysone treatment partially rescues rough phenotype.
a. immunofluorescence images showing that treating with 20-HE partially
rescues the apoptotic defect observed in GMR>DeIF6 40 hours APF retinae.
b. Representative graph showing the adult fly size with or without 20-HE
treatment. The reduced fly eye size associated with GMR>DeIF6 genotype is
partially rescue after 20-HE treatment. Graph represents mean ± SD. Statistic
used was t-test, two tails, paired. Experiment was repeated at least three times.
Discussion
Here, we present the first in vivo model of eif6 increased gene dosage, using
Drosophila eye. Our starting point was the knowledge that eIF6 is upregulated or
hyperphosphorylated in several cancer types, and that eif6 locus is amplified in
luminal breast cancer, but the early effects of this upregulation are still unclear.
We demonstrate that higher levels of eIF6, which is a factor necessary for ribosome
biogenesis and translation, are sufficient to induce an increase in ribosome biogenesis
and general translation that generates a complex transcriptional and metabolic
reprogramming. This in turn blocks apoptosis and causes the shutoff of hormonal
production (Figure 30). Rescue of hormonal supply partly reverts apoptosis and
the related developmental deficits, demonstrating that translation acts upstream of
transcription and metabolism in vivo.
Specifically, we show that a modulation of eIF6 expression during development or
in the whole organism is incompatible with life. The Drosophila DeIF6 shares 90%
of similarity with its human homologue. We decided to take advantage of the fly
model and its genetic tools [131] to modulate DeIF6 gene dosage in vivo and analyze
the early effects of eIF6 increased levels. To avoid the viability issue of the intact
organism, we increased DeIF6 levels only in the fly eye, a dispensable organ, that
is widely used for its well known structure and development [132]. Intriguingly,
upon DeIF6 overexpression we observed a rough eye phenotype, that we deeply
characterized during development. We demonstrated three major features associated
with increased DeIF6 protein levels: an increase in general translation, a delayed
and aberrant apoptosis and a total shutdown of the ecdysone hormonal pathway.
46
47
Figure 30: Model for DeIF6 high levels-associated changes. We demonstrated that in-
creased levels of DeIF6 are associated to increased general translation, resulting
in a transcription rewiring. RNASeq analysis confirms that altering deif6 gene
dosage modulates apoptosis during development and interestingly, reveals a
shutdown of genes involved in 20-HydroxyEcdysone biosynthesis. In addition,
we found an upregulation of genes related to chromatin organization.
We will discuss them separately.
In recent years, many studies have highlighted how alterations in the ribosomal
machinery and/or in translational control are involved in several pathologies, [133].
Indeed, increased expression of some ribosomal proteins (RPs) and of eukaryotic
Initiation Factors (eIFs) has been found in many cancer types [134–136]. Increased
protein synthesis was often interpreted as a general by-product of increased prolifer-
ation. Recently, instead, it has become evident that deregulation of the translational
machinery can be causative of cancer. Translation is the most energy consuming
process in cells [9]. For this reason, translation is tightly regulated, mostly in its
initiation step. The eukaryotic initiation factor eIF6, which is essential for both
ribosome biogenesis and translation initiation [23, 42], was found upregulated in
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many cancer types, including breast cancer, colorectal cancer and mesothelioma [40,
41, 45]. Consistently, haploinsufficiency of eIF6 protects mice from lymphomagenesis
in an Eµ-Myc model [43]. eIF6 acts by increasing the translational capability of cells
upon growth factor stimulation. eIF6 is an essential player in the control of initiation
of translation, because of the need to release it from the 60S for the joining of the two
ribosomal subunits and the following initiation of translation [23, 137]. In our eIF6
overexpressing model, we observed an unexpected increase in mRNAs encoding for
ribosomal proteins and rRNA processing factors, suggesting that ribosome biogenesis
is upregulated when eIF6 levels are higher than normal. Interestingly, we also showed
that the overexpression of DeIF6 causes a two-fold increase of general translation,
measured as puromycin incorporation, both in the developing eye and wing. This
new mechanistic effect extends the previous observation that demonstrated the role
of eIF6 in the translation of uORFs containing mRNAs [44, 138]. These data, taken
together, show that eIF6 can act in a feed-forward loop that amplifies the efficiency
of the translational machinery, and suggest that the upregulation of eIF6 may give
advantage to cancer cells, through an upregulation of both ribosome biogenesis and
general translation, both necessary to sustain the high proliferative rate of malignant
cells.
It is also possible that an increase in general translation such as the one dictated by
excess eIF6 impacts tumour cell fate in other ways, beyond the immediate necessity
of an augmented protein synthesis. A possible answer to this is represented by the
inhibition of physiological PCD in the fly eye during the pupal stage [105] upon
DeIF6 overexpression. A similar observation was made in X. laevis [139]. The
deregulation of PCD is in itself responsible for the rough eye phenotype observed in
condition of increased DeIF6 levels. In addition to this observation, here we defined
a molecular array of events that precedes and follows the inhibition of apoptosis. By
high-throughput gene expression analyses we found that an upregulation of general
translation causes a gross change in the transcriptome that has a coordinated impact
in biological processes, including apoptosis. We performed two independent gene
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expression analyses, in two distinct developmental windows: the first in the larva, to
appreciate the early events associated to DeIF6 overexpression, the latter in mid
pupal stage, when we experimentally observed the apoptotic defect. Interestingly, in
this last gene expression experiment, performed when the apoptotic wave shapes the
fly retina eliminating extra-numerary cells, we observed a global up-regulation of
genes involved in apoptosis. Overall, the effects of the manipulation of a translation
factor resulted in a change in apoptosis that is therefore explained by transcriptional
changes. This observation means that protein synthesis can acquire a driver role in
transcription, a feature stil under appreciated in molecular biology. In summary, our
data on apoptosis are consistent with two possibilities: developmental PCD could
be delayed by excess DeIF6. Alternatively, PCD could be repressed at the correct
developmental time and apoptotic elimination of defective cells overexpressing DeIF6
could be triggered later independently of developmental signals. The fact that
overexpression of DeIF6 in wing discs, which are not subjected to developmental
apoptosis, leads to cell death supports the latter hypothesis. Overall, these con-
siderations indicate that the advantage provided by excess DeIF6 to tumour cells
might initially consist in escape from apoptotic clearance. The following increase
in apoptosis that we observed later in development, at 60 hours APF, could be
dependent on an organ failure caused by the inability to remove excess cells. On
the contrary, tumors are not affected by this issue because they are not functional
organs, but parasitic structures.
Gene expression analysis performed in the larvae strongly points to a total shutdown
of ecdysone biosynthesis and signaling. In our analysis, almost all of the mRNAs
of the ecdysone biosynthetic pathway are greatly transcriptionally downregulated,
some of them even completely turned off, and the ecdysone signaling pathway is
globally affected upon DeIF6 overexpression. In addition, 20-HE treatment led
to a partial rescue of the pupal apoptotic defect and therefore of the rough eye
phenotype. Indeed, upon 20-HE treatment, we observed the partial rescue of PCD
at 40 hours APF and also the resulting adult eye presented a milder phenotype
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respect to not treated GMR>DeIF6 eyes. It is worth to note that the treatment
with the steroid hormone could only be an acute one: we could only treat larvae, but
upon pupariation and subsequent metamorphosis into adults, the developing flies do
not eat the flyfood containing the hormone. Therefore, it is possible that a more
continous treatment would result in a complete rescue of the phenotype. This issue
needs to be further covered in future experiments. Nonetheless, our data place DeIF6
upstream of ecdysone regulation, that is in turn responsible for the incapability
of DeIF6 overexpressing retinae to undergo apoptosis in the right developmental
window.
It has been established that epigenetic changes control the transcription of ecdysone
biosynthetic enzymes [140, 141]. We previously found that, in mammals, eIF6
haploinsufficiency caused a puzzling signature that mimicked alterations obtained by
histones acetylation inhibitors [44]. Intriguingly, our larval GSAA analysis unveils
that genes belonging to the chromosome organization gene set, such as Gcn5 and
Ada1-2, are upregulated when DeIF6 is overexpressed. Here, we showed that eIF6
expression leads to a decrease in HDACs activity. Overall, these data suggest that
DeIF6 overexpression causes a transcriptional reshaping that leads to complex epige-
netic changes which in turn prevent the transcription of mRNAs of the ecdysone
biosynthetic pathway. Curiously, an HTS screening for modulators of chromatin
structure, years ago identified as a major player another initiation factor [142].
Globally, these data bring translation to a center stage in the global regulation of
gene expression, at multiple levels. In summary, our study discloses for the first
time a regulation of a hormonal biosynthetic pathway dependent on an eukaryotic
translation factor that may act upstream of global and metabolic transcriptional
rewirings. The Drosophila model that we have established and presented here, may
be also used for an in vivo screening of suppressors of eIF6 overexpression that can
be useful in cancer therapy in view of the strong protumorigenic role of mammalian
eIF6.
Materials and Methods
Genetics
Fly strains were maintained on standard cornmeal food at 18°C. Genetic crosses were
performed at 25°C, with the exception of GMRGAL/+ and GMR>deIF6, performed
at 18°C. The following fly mutant stocks have been used: GMRGAL4/CTG was
a gift from Manolis Fanto (King’s College, London); UAS-DeIF6 was a gift from
William J Brook (Alberta Children’s Hospital, Calgary) [143]. Lines obtained from
the Bloomington Drosophila Stock Center (BDSC): spaGAL4 (26656), 54CGAL4
(27328) and w1118, UAS-p35 (5072), UAS-mCD8GFP (32184), MSGAL4 (8860).
Cell culture and transfections
HEK293T cells were grown in DMEM (Lonza) supplemented with 10% Fetal Bovine
Serum (FBS) and 1% penicillin, streptomycin, L-glutamine (Gibco) and maintained
at 37°C and 5% CO2. Mycoplasma testing was performed before experiments.
Cells were transfected with pcDNA3.1-eIF6 [29], or an empty vector, with Lipofec-
tamine®2000 (Invitrogen # 11668019) following manufacturer protocol.
RNA isolation and RNA sequencing
Total RNA was extracted with mirVanaTM isolation kit according to the man-
ufacturer protocols (mirVana ThermoFisher # AM 1560) from 10 eye imaginal
discs (larval stage) or 10 retinae (pupal stage). RNA quality was controlled with
BioAnalyzer. Libraries for Illumina sequencing were constructed from 100 ng of
total RNA with the Illumina TruSeq RNA Sample Preparation Kit v2 (Set A). The
generated libraries were loaded on to the cBot (Illumina) for clustering on a HiSeq
Flow Cell v3. The flow cell was then sequenced using a HiScanSQ (Illumina). A
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paired-end (2×101) run was performed using the SBS Kit v3 (Illumina). Sequence
deepness was at 35 millions reads.
Bioinformatic Analysis
Read pre-processing and mapping
Three biological replicates were analyzed for GMRGAL4/+ and GMR>DeIF6
larval eye imaginal discs and four biological replicates were analyzed for GMR-
GAL4/+ and GMR>DeIF6 pupal retinae, for a total of 14 samples. Raw reads
were checked for quality by FastQC software (version 0.11.2, S., A.FastQC: a
quality control tool for high throughput sequence data. 2010; Available from:
http://www.bioinformatics.babraham.ac.uk/projects/fastqc), and filtered to remove
low quality calls by Trimmomatic (version 0.32) [144] using default parameters and
specifying a minimum length of 50. Processed reads were then aligned to Drosophila
melanogaster genome assembly GRCm38 (Ensembl version 79) with STAR software
(version 2.4.1c) [145].
Gene expression quantification and differential expression analysis.
HTSeq-count algorithm (version 0.6.1, option -s = no, gene annotation release 79
from Ensembl) [146] was employed to produce gene counts for each sample. To
estimate differential expression, the matrix of gene counts produced by HTSeq was
analyzed by DESeq2 [147]. The differential expression analysis by DeSeq2 algorithm
was performed on the entire dataset composed by both larvae and pupae samples.
The two following comparisons were analyzed: GMR>DeIF6 versus GMRGAL4/+
larval eye imaginal discs (6 samples overall) and GMR>DeIF6 versus GMRGAL4/+
pupal retinae (8 samples in total). Reads counts were normalized by calculating a
size factor, as implemented in DESeq2. Independent filtering procedure was then
applied, setting the threshold to the 62 percentile; 10886 genes were therefore tested
for differential expression. Significantly modulated genes in GMR>DeIF6 genotype
were selected by considering a false discovery rate lower than 5%. Regularized
logarithmic (rlog) transformed values were used for heat map representation of
gene expression profiles. Analyses were performed in R version 3.3.1 (2016-06-21,
53
Computing, T.R.F.f.S. R: A Language and Environment for Statistical Computing.
Available from: http://www.R-project.org/).
Functional analysis by topGO
The Gene Ontology enrichment analysis was performed using topGO R Biocon-
ductor package. The option nodesize = 5 is used to prune the GO hierarchy from
the terms which have less than 5 annotated genes and the annFUN.db function is
used to extract the gene-to-GO mappings from the genome wide annotation library
org.Dm.eg.db for D. melanogaster. The statistical enrichment of GO was tested
using the Fisher’s exact test. Both the “classic” and “elim” algorithms were used.
Gene set association analysis
Gene set association analysis for larvae and pupae samples was performed by GSAA
software (version 2.0) [148]. Raw reads for 10886 genes identified by Entrez Gene
ID were analyzed by GSAASeqSP, using gene set C5 (Drosophila version retrieved
from http://www.go2msig.org/cgi-bin/prebuilt.cgi?taxid=7227) and specifying as
permutation type ‘gene set’ and as gene set size filtering min 15 and max 800.
Western blotting and antibodies
Larval imaginal discs, pupal retinae and adult heads were dissected in cold Phos-
phate Buffer Saline (Na2HPO4 10 mM, KH2PO4 1.8 mM, NaCl 137 mM, KCl 2.7
mM, pH 7.4) (PBS) and then homogenized in lysis buffer (HEPES 20 mM, KCl
100 mM, Glycerol 5%, EDTA pH 8.0 10 mM, Triton-X 0.1%, DTT 1mM) freshly
supplemented with Protease Inhibitors (Sigma # P8340). Protein concentration was
determined with BCA analysis (Pierce # 23227). Equal amounts of proteins were
loaded and separated on a 10% SDS-PAGE, then transferred on a PVDF membrane.
Membranes were blocked in 10% Bovine Serum Albumin (BSA) in PBS-Tween
(0.01%) for 30 minutes at 37°C. The following primary antibodies were used: rabbit
anti-eIF6 (1:500, this study), rabbit anti-β-actin (1:4000, CST # 4967). To produce
the anti-eIF6 antibody used in this study, a rabbit polyclonal antiserum against two
epitopes on COOH-terminal peptide of eIF6 (NH2-CLSFVGMNTTATEI-COOH
eIF6 203-215 aa; NH2-CATVTTKLRAALIEDMS-COOH eIF6 230-245 aa) was
54
prepared by Primmbiotech (Ab code: 201212-00003 GHA/12), purified in a CNBr-
Sepharose column and tested for its specificity against a mix of synthetic peptides
with ELISA test. The following secondary antibodies were used: donkey anti-mouse
IgG HRP (1:5000, Amersham # NA931) and donkey anti-rabbit IgG HRP (1:5000,
Amersham # NA934).
SUnSET Assay
Larval imaginal eye and wing discs were dissected in complete Schneider medium,
and treated ex vivo with puromycin (50 µg/mL) for 30 minutes at room temper-
ature, then fixed in 3% paraformaldehyde (PFA) for 1 hour at room temperature.
Immunofluorescences were then performed as described below, using a mouse anti
Puromycin (1:500 Merck Millipore # MABE343) as a primary antibody. Discs were
then examined by confocal microscope (Leica SP5) and fluorescence intensity was
measured with ImageJ software. For protein synthesis measurement in HEK293T
cells, after 48 hours of transfection with the pcDNA3.1-eIF6 or the empty vector,
we followed the adapted SUnSET protocol described in [149]. All experiments were
performed at least three times, in triplicate.
Cells count
GMRGAL4/+ and GMR>DeIF6 pupal retinae at 40h APF were dissected, fixed,
and stained with anti-Armadillo to count cells, as previously described (Cordero et
al., 2004). Cells contained within a hexagonal array (an imaginary hexagon that
connects the centres of the surrounding six ommatidia) were counted; for different
genotypes, the number of cells per hexagon was calculated by counting cells, com-
pared with corresponding control. Cells at the boundaries between neighbouring
ommatidia count half. At least 3 hexagons (equivalent to 9 full ommatidia) were
counted for each genotype, and phenotypes were analysed. Standard Deviation (SD)
was used as statistical analysis.
Immunofluorescences, antibodies and TUNEL Assay
Larval imaginal discs and pupal retinae were dissected in cold PBS and fixed in 3%
paraformaldehyde (PFA) for 1 hour at room temperature, then washed twice with
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PBS and blocked in PBTB (PBS, Triton 0.3%, 5% Normal Goat Serum and 2%
Bovine Serum Albumin) for 3 hours at room temperature. Primary antibodies were
diluted in PBTB solution and incubated O/N at 4°C. After three washes with PBS,
tissues were incubated O/N at 4°C with secondary antibodies and DAPI (1:1000,
Molecular Probes # D3571) in PBS. After three washes with PBS, eye imaginal discs
and retinae were mounted on slides with ProLong Gold (LifeTechnologies # P36930).
The following primary antibodies were used: rabbit anti-eIF6 (1:50, this study), rat
anti-ELAV (1:100, Developmental Study Hybridoma Bank DSHB # 7E8A10), mouse
anti-CUT (1:100, DSHB # 2B10), mouse anti-Rough (1:100, DSHB # ro-62C2A8),
mouse anti-Armadillo (1:100, DSHB # N27A), mouse anti-Chaoptin (1:100, DSHB
# 24B10), rabbit anti- Dcp-1 (1:50, CST # 9578), mouse anti-Puromycin (1:500,
Merck Millipore # MABE343). The following secondary antibodies were used: don-
key anti-rat, donkey anti-mouse, donkey anti-rabbit (1:500 Alexa Fluor®secondary
antibodies, Molecular Probes). Dead cells were detected using the In Situ Cell
Death Detection Kit TMR Red (Roche # 12156792910) as manufacturer protocol,
with some optimization. Briefly, retinae of the selected developmental stage were
dissected in cold PBS and fixed with PFA 3% for 1 hour at room temperature. After
three washes in PBS, retinae were permeabilized with Sodium Citrate 0.1%-Triton-X
0.1% for 2 minutes at 4°C, and then incubated overnight at 37°C with the enzyme
mix. Retinae were then rinsed three times with PBS, incubated with DAPI to
stain nuclei and mounted on slides. Discs and retinae were examined by confocal
microscopy (Leica SP5) and analysed with Volocity 6.3 software (Perkin Elmer). All
immunofluorescences were performed at least on three independent experiments.
Semithin sections
Semithin sections were prepared as described in [150]. Adult eyes were fixed in 0.1
M Sodium Phosphate Buffer, 2% glutaraldehyde, on ice for 30 min, then incubated
with 2% OsO4 in 0.1 M Sodium Phosphate Buffer for 2 hours on ice, dehydrated in
ethanol (30%, 50%, 70%, 90%, and 100%) and twice in propylene oxide. Dehydrated
eyes were then incubated O/N in 1:1 mix of propylene oxide and epoxy resin (Sigma,
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Durcupan™ACM). Finally, eyes were embedded in pure epoxy resin and baked O/N
at 70°C. The embedded eyes were cut on a Leica UltraCut UC6 microtome using
a glass knife and images were acquired with a 100X oil lens, Nikon Upright XP61
microscope.
Ecdysone treatment
For ecdysone treatment, 20-HydroxyEcdysone (20HE) (Sigma # H5142) was dis-
solved in 100% ethanol to a final concentration of 5 mg/mL; third instar larvae from
different genotypes (GMRGAL4/+ and GMR>DeIF6) were collected and placed
in individual vials on fresh standard cornmeal food supplemented with 240 µg/mL
20-HE. Eye phenotype was analyzed in adult flies, and images were captured with a
TOUPCAM™Digital camera. Eye images were analyzed with ImageJ software.
In vitro Ribosome Interaction Assay (iRIA)
iRIA assay was performed as described in [151]. Briefly, 96-well plates were coated
with a cellular extract diluted in 50 µL of PBS, 0.01% Tween-20 O/N at 4 °C in
humid chamber. Coating solution was removed and aspecific sites were blocked with
10% BSA, dissolved in PBS, 0.01% Tween-20 for 30 minutes at 37 °C. Plates were
washed with 100 µL/well with PBS-Tween. 0.5µg of recombinant biotynilated eIF6
were resuspended in a reaction mix: 2.5 mM MgCl2, 2% DMSO and PBS-0.01%
Tween, to reach 50µL of final volume/well, added to the well and incubated with
coated ribosomes for 1 hour at room temperature. To remove unbound proteins, each
well was washed 3 times with PBS, 0.01% Tween-20. HRP-conjugated streptavidine
was diluted 1:7000 in PBS, 0.01% Tween-20 and incubated in the well, 30 minutes at
room temperature, in a final volume of 50 µL. Excess of streptavidine was removed
through three washes with PBS-Tween. OPD (o-phenylenediamine dihydrochloride)
was used according to the manufacturer’s protocol (Sigma-Aldrich) as a soluble
substrate for the detection of streptavidine peroxidase activity. The signal was
detected after the incubation, plates were read at 450nm on a multiwell plate reader
(Microplate Bio-Rad model 680). This experiment was performed at least three
times, in triplicate.
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HDACs activity
HDACs activity was measured with the fluorometric HDAC Activity Assay kit
(Sigma # CS1010-1KT) according to the manufacturer’s instructions. Briefly, cells
were lysed with a buffer containing 50 mM HEPES, 150 mM NaCl, and 0.1% Tri-
ton X-100 supplemented with fresh protease inhibitors. 20 µg of cell lysates were
incubated with assay buffer containing the HDACs substrate for 30 minutes at 30°C.
The reaction was terminated, and the fluorescence intensity was measured in a
fluorescence plate reader with Ex.=350-380nm and Em.=440-460nm.
Statistical Analysis
Each experiment was repeated at least three times, as biological replicates; means
and standard deviations between different experiments were calculated. Statistical
p-values obtained by Student t-test were indicated: three asterisks *** for p-values
less than 0.001, two asterisks ** for p-values less than 0.01 and one asterisks * for
p-values less than 0.05.
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